Sort
39,280 grants matching “leukemia”
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
$387,412James Douglas Engel · University Of Michigan At Ann Arbor · R01 · FY2016 · AI
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
$387,412James Douglas Engel · University Of Michigan At Ann Arbor · R01 · FY2015 · AI
Role Of Nuclear Organization In Protecting Genome Stability During Recombination
$387,408Jane Amanda Skok · New York University School Of Medicine · R01 · FY2015 · GM
Role Of Nuclear Organization In Protecting Genome Stability During Recombination
$387,408Jane Amanda Skok · New York University School Of Medicine · R01 · FY2014 · GM
Role Of Nuclear Organization In Protecting Genome Stability During Recombination
$387,408Jane Amanda Skok · New York University School Of Medicine · R01 · FY2016 · GM
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$387,339Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2024 · CA
Telomere length control by shelterin
$387,306Titia De Lange · Rockefeller University · R01 · FY2010 · CA
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling
$387,250Jing Chen · Emory University · R01 · FY2015 · CA
Mapping for Specialized Domains for FCeRI Signaling & Internalization
$387,209Bridget S Wilson · University Of New Mexico Health Scis Ctr · R01 · FY2012 · AI
Endothelial Progenitor Cell Transplant to Accelerate Hematopoietic Recovery
$387,200John P Chute · Duke University · R01 · FY2008 · HL
Mechanisms of Parp inhibitor-induced bone marrow toxicities
$387,195Jane Ellen Churpek · University Of Wisconsin-Madison · R01 · FY2025 · HL
A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer
$387,195Eric J Duncavage · Washington University · R33 · FY2025 · CA
Control of neural stem cells by the nascent cerebrospinal fluid
$387,188Maria Lehtinen · Boston Children'S Hospital · R01 · FY2016 · NS
Control of neural stem cells by the nascent cerebrospinal fluid
$387,188Maria Lehtinen · Boston Children'S Hospital · R01 · FY2019 · NS
Control of neural stem cells by the nascent cerebrospinal fluid
$387,188Maria Lehtinen · Boston Children'S Hospital · R01 · FY2017 · NS
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$387,183Peter A Cohen · Mayo Clinic Rochester · P50 · FY2017 · CA
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD
$387,168Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2003 · CA
Role of TET proteins in myeloid malignancies
$387,133Anjana Rao · La Jolla Institute For Immunology · R01 · FY2014 · CA
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies
$387,128Kris C. Wood · Duke University · R01 · FY2024 · CA
Implications of Metabolic Regulation of BCL-2 Dependence for Myeloma Therapy
$387,117Malathy (mala) Shanmugam · Emory University · R01 · FY2018 · CA
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma
$387,106Michael D Hogarty · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Incorporating FLT3 Inhibitors into AML Treatment Regimens
$387,019Mark J Levis · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Deep Proteomic Profiling of Rare Cells
$386,992Alexander R. Ivanov · Northeastern University · R01 · FY2017 · GM
Deep Proteomic Profiling of Rare Cells
$386,992Alexander R. Ivanov · Northeastern University · R01 · FY2019 · GM
Deep Proteomic Profiling of Rare Cells
$386,992Alexander R. Ivanov · Northeastern University · R01 · FY2018 · GM